We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A group of 10 moderate House Democrats have written to Speaker Nancy Pelosi (D-Calif.) urging her to embrace bipartisan drug pricing legislation, signaling a cooperative effort as a more realistic way to get a drug pricing bill to the Oval Office. Read More
The FDA has finalized guidance on qualified infectious disease product (QIDP) designations, drug designations that are meant to encourage the development of certain antibacterial and antifungal products for serious or life-threatening infections. Read More
The House on Tuesday failed to pass the Fairness in Orphan Drug Exclusivity Act, a bill that would have closed an orphan drug exclusivity loophole used to prevent competing drugs from hitting the market, with Republican opposition barring it from moving onwards to the Senate. Read More
Eli Lilly has partnered with UK-based MiNA Therapeutics to develop treatments using small activating RNA (saRNA) technology, a new class of drugs pioneered by MiNA. Read More
The FDA has finalized guidance on post-approval chemistry, manufacturing and control (CMC) changes developed in collaboration with the International Council for Harmonization (ICH). Read More
Bayer said its experimental drug finerenone delayed the progression of chronic kidney disease (CKD) in patients with type 2 diabetes in a late-stage study. Read More